Compare Stocks

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Belgravia Capital International Inc. focuses on incubation, investments, and royalty and management services businesses. The company offers capital to support the development of early stage companies in the biotech/healthcare, technology, resources, and medical sectors, as well as to support the international expansion on a selective basis. It also invests in various private and public companies with a focus on value; and provides merchant banking services. The company was formerly known as IC Potash Corp. and changed its name to Belgravia Capital International Inc. in November 2017. Belgravia Capital International Inc. is based in Toronto, Canada.

K+S Aktiengesellschaft, together with its subsidiaries, operates as a supplier of mineral products for the agricultural, industrial, consumer, and community sectors worldwide. It offers potassium chloride for crops, such as grain, corn, rice, and soybean; fertilizer specialties that are used for crops with magnesium and sulfur requirements, including rapeseed and potatoes, as well as for chloride-sensitive crops consisting of citrus, grapes, and vegetables; and water-soluble fertilizers for use in fertigation of fruit and vegetables under the KALISOP, KORN-KALI, ROLL-KALI, PATENTKALI, ESTA KIESERIT, MAGNESIA-KAINIT, SOLUMOP, SOLUSOP, SOLUCMS, SOLUMAP, SOLUMKP, EPSO TOP, EPSO MICROTOP, EPSO COMBITOP, EPSO PROFITOP, and EPSO BORTOP brands. The company also provides melting salts, sodium chloride, natural rock salt, high-purity vaccum salt and natural sea salt, potassium chloride, Epsom salt, minerals for pets and livestock, aluminum recycling, salt licks for farm and wild animals under the Alasal, APISAL, AXAL PRO, NUTRIKS, NUTRIKS KaliSel, KASA, k-DRILL, Montanal, and SOLSEL brand names. In addition, it offers table salts under the SALDORO, Cérébos, and Vatel brands; salts for water treatment; dishwashing salts; and de-icing salts. K+S Aktiengesellschaft was founded in 1889 and is headquartered in Kassel, Germany.

K+S Aktiengesellschaft, together with its subsidiaries, operates as a supplier of mineral products for the agricultural, industrial, consumer, and community sectors worldwide. It offers potassium chloride for crops, such as grain, corn, rice, and soybean; fertilizer specialties that are used for crops with magnesium and sulfur requirements, including rapeseed and potatoes, as well as for chloride-sensitive crops consisting of citrus, grapes, and vegetables; and water-soluble fertilizers for use in fertigation of fruit and vegetables under the KALISOP, KORN-KALI, ROLL-KALI, PATENTKALI, ESTA KIESERIT, MAGNESIA-KAINIT, SOLUMOP, SOLUSOP, SOLUCMS, SOLUMAP, SOLUMKP, EPSO TOP, EPSO MICROTOP, EPSO COMBITOP, EPSO PROFITOP, and EPSO BORTOP brands. The company also provides melting salts, sodium chloride, natural rock salt, high-purity vaccum salt and natural sea salt, potassium chloride, Epsom salt, minerals for pets and livestock, aluminum recycling, salt licks for farm and wild animals under the Alasal, APISAL, AXAL PRO, NUTRIKS, NUTRIKS KaliSel, KASA, k-DRILL, Montanal, and SOLSEL brand names. In addition, it offers table salts under the SALDORO, Cérébos, and Vatel brands; salts for water treatment; dishwashing salts; and de-icing salts. K+S Aktiengesellschaft was founded in 1889 and is headquartered in Kassel, Germany.